Background. Infections and malignancies are the most common non-cardiovascular causes of death in patients on chronic renal replacement therapy (RRT). Here, we aimed to quantify the mortality risk attributed to infections and malignancies in dialysis patients and kidney transplant recipients when compared with the general population by age group and sex. Methods. We followed 168 156 patients included in the ERA-EDTA registry who started RRT in 1993-2007 until 1 January 2012. Age-and cause-specific mortality rates per 1000 personyears ( py) and mortality rate ratios (MRRs) compared with the European general population (WHO) were calculated. To identify risk factors, we used Cox regression.
malignancy-related death is moderately increased. Young women on dialysis may deserve special attention because of their high excess risk of infection-related mortality. Further research into the mechanisms, prevention and optimal treatment of infections in this vulnerable population is required.
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I N T RO D U C T I O N
Death rates in patients treated with chronic renal replacement therapy (RRT) are substantially higher than in the general population [1] . Cardiovascular diseases have been recognized as the main cause of death in both dialysis and transplanted patients. Nevertheless, most patients die from non-cardiovascular causes, with infections and cancer being the most common ones [1] .
When compared with the general population, dialysis patients have been reported to have an up to 100-fold increase in age-adjusted risk of mortality due to infections associated with sepsis, as well as a 10-fold increased risk of death due to pulmonary infections. These risks were 20-and 2-fold increased, respectively, among transplant recipients [2, 3] . Furthermore, many studies have shown that transplanted patients have a 3-to 4-fold increased risk of fatal and especially non-fatal cancer, while in dialysis patients the risk of non-fatal cancer is only marginally increased [4, 5] .
The UK Renal Registry data have shown that over the last decade there has been an important decrease in cardiovascular mortality (from 34% in 2000 to 22% in 2011) [6] , but similar trends have not been observed for death due to infections and malignancies (stable around 18 and 10%, respectively) [6, 7] . In a previous study we found an increased mortality due to noncardiovascular causes in women treated with chronic dialysis treatment compared with men, especially among women treated with peritoneal dialysis [7, 8] . We therefore hypothesized that infection rates might be higher in females than in males. However, to date, information on the interaction of sex, age and primary renal disease with infection-and malignancy-related mortality in RRT patients is lacking.
In this study we therefore aimed (i) to quantify the occurrence of the most common non-cardiovascular causes of death, infections and malignancies, in patients treated with dialysis or living with a kidney transplant, (ii) to compare rates of these fatal events with those in the general population and (iii) to assess the role of age, sex and primary renal disease as determinants of mortality due to infections and malignancies in these patients.
M AT E R I A L S A N D M E T H O D S
Data collection and study population The European Renal Association-European Dialysis and Transplantation Association (ERA-EDTA) Registry collects data on RRT patients via national and regional renal registries in Europe. These data include the date of birth, sex, primary renal disease, date of start of first RRT for end-stage renal disease, changes in treatment modality and date and cause of death. We included data from registries providing sufficiently complete data on cause of death, i.e. <25% missing or unknown. Patients starting RRT between 1 January 1993 and 31 December 2007 were followed until 1 January 2012. In total, 20 registries participated in the study, including the national registries of Austria, Denmark, Finland, Greece, Iceland, the Netherlands, Norway and Sweden, and the regional registries of Dutch-and French-speaking Belgium, Calabria (Italy), Andalusia (Spain), Aragon (Spain), Asturias (Spain), Basque Country (Spain), Catalonia (Spain), Castilla-la Mancha (Spain), Canary Islands (Spain), Extremadura (Spain) and Scotland (the UK). All renal registries had 100% coverage of the population in their corresponding region. RRT patients were defined as dialysis patients (haemodialysis and peritoneal dialysis patients combined) and renal transplant recipients. Some patients who were transplanted during the study period also had periods on dialysis, either before or after the kidney transplantation, and they fell into both categories. We defined two non-cardiovascular mortality groups using the ERA-EDTA coding system for causes of death [1] . Death due to infections included codes 31-39, 41, 42 and 100-102, whereas death due to malignancies comprised codes 66-68. Of the infection-related codes, number 35 represented septicaemia and 31-33 and 36 represented pulmonary infections. We did not evaluate other specific causes of non-cardiovascular mortality. Primary renal disease was categorized as glomerulonephritis/sclerosis, pyelonephritis, polycystic kidneys adult type, diabetes mellitus, hypertension/ renal vascular disease, multisystem disease, cancer, miscellaneous and unknown/missing. The category cancer included those primary renal diseases coded as kidney tumour (95) or myelomatosis/light-chain deposit disease (82), while the category multisystem disease included granulomatosis with polyangiitis (Wegener's granulomatosis, 74), renal vascular disease due to polyarteritis (73), glomerulonephritis related to liver cirrhosis (76), cryoglobulinaemic glomerulonephritis (78), amyloid (83), lupus erythematosus (84), Henoch-Schönlein purpura (85), Goodpasture's syndrome (86), systemic sclerosis (scleroderma; 87) and other multisystem diseases (89).
As a reference, mortality data from the general population of the same 20 countries and regions for the same period were obtained from the World Health Organization (WHO) (www. who.int). WHO provides cause-specific mortality data, classified by International Statistical Classification of Diseases, 10th Revision (ICD-10) codes, stratified by 5-year age categories and sex [9] . Infections were classified according to codes A00-B99, J10-J11 and J12-J18, while malignancies were classified according to codes C00-D48 [9] .
Data analyses
Patients were classified by age (into 10-year age categories) and sex. For dialysis patients, the person-time on dialysis was calculated using both naive and post-transplant dialysis periods. As there were no differences in mortality between these types of dialysis periods, we report results for total time on dialysis only. For dialysis patients, follow-up time was measured until recovery of renal function, kidney transplantation, loss
N o n -c a r d i o v a s c u l a r m o r t a l i t y i n R R T p a t i e n t s to follow-up and end of the follow-up period, whichever came first. For transplanted patients we used the person-time of the first functioning graft; the event studied was death while living with a kidney transplant or death within 60 days after return to dialysis. The follow-up time for these patients was measured until the end of the first 60 days on dialysis, loss to follow-up or end of the follow-up period.
Age-specific mortality rates [ per 1000 person-years( py)] were calculated by dividing the total number of deaths due to infections or malignancies by the total person-time lived in that age stratum, according to treatment modality (in the RRT population) and sex (in both the RRT population and the general population). Excess mortality risk was calculated in two ways. First, mortality rate ratios (MRRs), adjusted for 5-year age groups and sex, were calculated to compare mortality in RRT patients with that in the general population. Confidence intervals were calculated according to the Poisson Exact method using MedCalc Statistical Software version 13.1.1. We also calculated the MRRs for malignancy as cause of death excluding patients with malignancies as cause of primary renal disease (ERA-EDTA code 95). For the calculation of MRRs we used direct standardization. The mortality rates in both transplant recipients and dialysis patients were weighted by the age distribution of the general population. Second, to study the effect of primary renal disease, and the effects of age and gender in more detail, we performed survival analysis among the dialysis patients and transplant recipients. We performed Cox regression models to calculate adjusted hazard ratios (HRs) with 95% confidence intervals (95% CI). In these Cox regression analyses we applied four main groups of primary renal disease; glomerulonephritis, diabetes mellitus, cancer and multisystem disease. Patients in other primary renal disease groups were included in the analyses; however, their results are not presented.
R E S U LT S
Study population
Between 1993 and 2007, 168 156 patients started RRT in the included registries (Table 1) . Median age at start was 66.0 years and 61.2% of the patients were men. Of all patients, 82.0% started RRT with haemodialysis, 16.0% with peritoneal dialysis and 2.1% received a pre-emptive renal transplant.
The median follow-up time in dialysis patients was 2.4 (interquartile range [IQR] 0.9-4.7) years. Median follow-up time for the 44 540 patients who received a transplant was 5.2 years (IQR 2.4-8.8).
A total of 112 653 patients died; 36.4% due to cardiovascular causes and 48.2% due to non-cardiovascular causes. In 15.5% of the patients the cause of death was unknown. Of the non-cardiovascular deaths, 18 273 (16.2% of the total number of deceased patients) died from infections and 8744 (7.8%) from malignancies. Other non-cardiovascular causes accounted for 24.2% of deaths of which haemorrhages (2.7%), cachexia (3.2%) and withdrawal (7.9%) were the most common causes. The general population in the corresponding subgroups of ageand sex in the different countries covered 1.5 billion py over the observation period and 49.2% were men. Of the general population 9.6% died during follow-up, and among the deceased persons 39.8% died of cardiovascular causes, 58.1% died of noncardiovascular causes and 2.1% from unknown causes. Of all deaths, 3.6% were due to infections and 25.8% due to malignancies.
Infection-related mortality Dialysis patients. Among dialysis patients, the mortality rate from infections was 30.5 per 1000 py (95% CI 30.0-31.0, Table 2 ). Of these, the mortality rates for septicaemia, pulmonary infections and other infections were 20.2, 7.0 and 4.4 per 1000 py, respectively. Among patients in whom the causative agent was known (87.4%), 95.9% died from bacterial infections, 2.6% from viral infections and 1.4% from other types of infections (fungal, protozoal or parasitic).
Mortality rates due to infections were much higher than in the general population and increased in proportion with ageing. Nevertheless, when studying mortality rates stratified by age category, the dialysis patients aged 0-19 years were at higher risk of infection-related death (7.6 per 1000 py, 95% CI 4.8-11.5) than the oldest members of the general population >80 years (5.7 per 1000 py).
After adjustment for age and sex, the infection-related mortality in dialysis patients was highly increased, compared with the general population, with an adjusted MRR of 81.6 (95% CI 79.6-83.6). In contrast to the absolute mortality rates, the age-specific MRRs of infection-related death strongly decreased with age ( Figure 1A ).
Transplant recipients. Among transplant recipients, the mortality rate due to infections was 6.8 per 1000 py (95% CI 6.5-7.1, Table 2 ). Septicaemia, pulmonary infections and other infections accounted for 3.2, 1.6 and 0.9 deaths per 1000 py, respectively. Bacterial infections were less common than in dialysis patients (85.3%), 8.9% died of viral infections and 5.9% of other types of infections. Mortality rates for infection-related death were substantially higher than in the general population, increasing strongly with age. Again MRRs decreased with age ( Figure 1B) . The age and sex-adjusted MRR for infection-related mortality in transplant patients was 31.5 (95% CI 29.6-33.4).
Association of sex, age and primary renal disease to mortality. In both dialysis patients and transplant recipients, mortality rates were comparable for both sexes. In contrast, women had a higher age-adjusted MRR of dying from infections than men: 98.8 (95% CI 95.9-102) versus 67.7 (95% CI 65.5-69.9) among dialysis patients and 39.2 (95% CI 36.1-42.4) versus 25.3 (23.1-27.7) among transplant recipients (Table 3) . Among dialysis patients, Cox regression analysis with adjustment for age, country and year of start of RRT, revealed a 7% higher risk of infection-related death for women when compared with men (adjusted HR 1.07 95% CI 1.04-1.10) ( Table 4) . Among the recipients of a first kidney transplant, women on average had a similar risk of infection-related death compared with men (adjusted HR 1.01 95% CI 0.92-1.11).
When stratified by age, women on dialysis aged 0-39 years had an extremely high MRR of infection-related mortality (>500-fold increased). In that age category, women on dialysis had a 32% higher risk of infection-related death compared with similar-aged men. Overall, women with a renal transplant had a 54% higher risk of infection-related death compared with men in the same age category (Table 4 ). In transplant recipients this differential risk between men and women was more prominent in patients aged 20-40 years while in transplant recipients aged >40 years this sex difference disappeared (Table 4) .
All patients on dialysis with multisystem disease as primary cause of renal disease were at excess risk of dying from infections as compared to the general population (14.3 and 16.2 deaths/1000 py in women and men, respectively). Even within the RRT population they had a 2-fold increased risk of death as compared to patients with glomerulonephritis (adjusted HR of 2.26 (95% CI 2.09-2.45) in dialysis and 2.13 (95% CI 1.73-2.63) in transplant patients, Table 4 ). In addition, the prevalence of multisystem disease was two times higher in women than in men, especially in the young age categories (Figure 2 ). Even after adjustment for primary renal disease and the dialysis modality, young women on dialysis or with a transplant still had a higher risk of infection-related death than men (HR 1.42 95% CI 1.13-1.80 and 1.53 95% CI 1.06-2.22, for dialysis patients and transplant recipients respectively).
Malignancy-related mortality Dialysis patients. Among dialysis patients there were 14.0 deaths per 1000 py (95% CI 13.7-14.4) due to malignancies (Table 2) . Mortality rates were almost three times higher than in the general population (age and sex-adjusted MRR 2.9 (95% CI 2.8-3.1), Table 2 , Figure 1C and Table 3 ). If patients with malignancies as primary renal disease were excluded, the adjusted MRR was 2.2 (Table 3) .
Transplant recipients. Among the transplant recipients there were 4.6 deaths per 1000 py (95% CI 4.3-4.8) because of malignancies (Table 2) . Compared with the general population, the mortality from malignancies was significantly increased with an age-and sex-adjusted MRR of 1.7 (95% CI 1.6-1.8). This MRR was slightly lower after exclusion of patients with malignancies as primary renal disease. The MRRs from malignancies decreased with age ( Figure 1D ).
Association of sex, age and primary renal disease to mortality. Overall, women on RRT had a lower risk of dying from malignancies than men, which is in line with the trend observed for the general population. However, girls aged 0-19 years on dialysis had a relatively higher risk of dying from malignancies. Consequently, in the age group 0-40 years the female survival advantage observed in the general population was not present in the dialysis group (Table 3) .
Conversely, among older patients, female sex was associated with a lower risk of mortality from malignancies, which remained after adjustment for primary renal disease (Table 4 ). Exclusion of cancer as primary disease did not change these outcomes.
As presented in Table 4 , having cancer as primary cause of end-stage renal disease was associated with an almost 2-fold increased risk of cancer-related mortality. Both dialysis patients and transplant recipients under 40 years of age were at a 
O R I G I N A L A R T I C L E N o n -c a r d i o v a s c u l a r m o r t a l i t y i n R R T p a t i e n t s markedly increased risk of cancer mortality (2.2 and 3.3 times increased, respectively).
To a lesser extent also multisystem disease tended to be associated with a higher risk of dying of malignancies in the dialysis population.
D I S C U S S I O N
Most studies on mortality in end-stage renal disease patients emphasize the importance of cardiovascular disease as the major cause of death. Yet, most of these patients die of non-cardiovascular causes, of which infections and malignancies are most prominent [2] . In this large cohort of RRT patients, we confirmed that infection-related mortality was importantly increased in both dialysis patients and kidney transplant recipients. The risk of malignancy-related death, however, was only mildly increased as compared with the general population. We also identified young women to have a relatively higher risk of premature death by infections as compared with young females from the general population.
Infection-related mortality
We found that dialysis patients were at an 82 times increased risk of death by infection when compared with the general population. Fatal infections concerned bacterial infections in 96% of the cases. These findings are in line with previous studies in dialysis patients, in which bacterial infections were found to be the second leading cause of death, the majority of casualties due to septicaemia [10] . A study based on data from the Unites States Renal data System (USRDS) during the period [1994] [1995] [1996] showed that patients on dialysis had an up to 100-fold increase in age-adjusted risk of mortality from infections associated with sepsis and a 10-fold increased risk of death from pulmonary infections [2, 3] . Similarly, we found that in dialysis patients the mortality rate from infections associated with sepsis was 20.2/ 1000 py, but we could not extract a comparable rate for the general population. Our death rate due to septicaemia and pulmonary infections (27.8 per 1000 py) in dialysis patients was very similar to that reported in the United States (US, 26/1000) [10] .
We observed important differences in the risk of infectionrelated deaths between both sexes, especially among dialysis patients. The relative risk as compared with men was markedly increased in younger women, a phenomenon that was partially explained by their higher prevalence of multisystem disease, mainly lupus erythematosus. Patients with multisystem disease are at higher risk of infections, possibly due to an altered immune response or use of immunosuppressive medication. However, after adjustment for multisystem disease, we still found a 1.4-fold (95% CI 1.08-1.91) increased risk among women younger than 40 years, suggesting a role for additional factors. This finding is in line with a recent study in peritoneal dialysis patients from Andalusia, Spain, which showed a 2-fold increased risk of infection-related death among women as compared with men [8] . In the general population the risk of death due to infections is extremely low and women have even lower death rates than men. While the high infection-related MRR in young women may be partially explained by the low risk in women in the general population, this finding suggests a loss of the 'survival advantage' of women regarding infection-related causes of death [11] . The fact that the largest differences between men and women in our study occurred at relatively young age may suggest a role of sex hormones on the immune system [12] . In females, phagocyte function of neutrophils is enhanced by oestrogen [13] while testosterone has a suppressive effect on immune responses, among others on macrophage function and increases susceptibility to infections [14] . Among women on dialysis, oestradiol levels are generally lower than in transplant recipients [15] and the general population [16] , which explains the loss of gender advantage. Subsequently, we speculate that a reduced immune response in young women on dialysis, in addition to a higher prevalence of multisystem disease (further compromising the immune system) may be a potential explanation for this observation.
When patients die of cardiovascular disease they are no longer able to die from infections. Therefore, if males would die more often from cardiovascular-related causes, at the cost of infections, this could explain the gender difference for infectious death. However we previously showed that the standardized mortality rates for cardiovascular death were similar between both sexes [1] . Therefore we do not believe that this could explain the gender difference for infectious-related death.
Another reason for the reported sex difference may be related to the choice of vascular access. Several studies, including the Dialysis Outcomes and Practice Patterns Study (DOPPS) and Scottish data, have shown that sepsis/infection occurs more often in patients with a central venous catheter than in patients with an arteriovenous fistula (AVF) or graft [17] [18] [19] [20] [21] [22] . According to the USRDS, in 2007 22.9% of women used a catheter, versus 13.3% of men, while 44.3% of women had an AVF, versus 64.2% of the men. Women also had more often an arteriovenous graft [17] . Similar proportions were observed in a recent study based on data from the ERA-EDTA Registry. Moreover, this study showed that the risk of infectious death was strongly reduced in women with an AVF when compared to women with other vascular access types [23] .
Concerns about smaller vascular diameters and reports of higher failure rates in women may prevent nephrologists and surgeons from considering AVF for female dialysis patients and might justify the preferred utilization of catheters in women [24] . These concerns are questionable, since Caplin et al. showed that women have as adequate a vasculature for the placement of AVFs as men [25] .
Among transplant recipients, infections were the second leading cause of death (20.8%) after cardiovascular disease (29.3%), similarly to reports from the US [20] and the UK [6] . We showed that in these individuals the mortality rate from infections was 6.8 per 1000 py, and mortality from infections associated with sepsis was 4.0 per 1000 py. In transplant patients the risk of dying from infections was 31.5 times higher F I G U R E 1 : Differences in mortality rate/1000 py and MRRs for infections (A and B) and malignancies (C and D) among dialysis patients (A and C) and transplant recipients (B and D). Mortality rate/1000 py is shown on the left scale and increases with age. Mortality rate ratio is shown on the right scale and decreases with age. than in the general population, which is in line with previous reports [2, 3] . Possible causes of the high death rate in renal transplant recipients are the use of immunosuppressants and defective phagocytic function of granulocytes [2] .
Malignancy-related mortality
We found an almost 3 times increased risk of death due to malignancies in dialysis patients, similar to previous studies [26] [27] [28] . A recent review suggested that the incidence of cancer was increased in patients with chronic kidney disease both before and after the start of RRT, and that dialysis patients had an 1-to 2-fold increased risk of developing cancer as compared with the general population [4] . Women in the older age groups had a survival advantage with respect to malignancies as cause of death. Previous studies in the general population have shown this survival benefit among older women and this is a wellknown phenomenon for anorectal carcinomas as well as for other tumour groups [29, 30] . Environmental, behavioural and biological factors have been assumed to contribute to this sex difference, but the exact mechanism has still to be elucidated [29] . In addition, we noted that patients with diabetes had a lower risk of death due to malignancies. We have no explanation for this. However as the risk of cardiovascular death is very high in patients with diabetic nephropathy [31] , we could speculate that patients may not survive long enough to develop fatal malignancies, especially as this hazard is compared with that among the relatively healthy glomerulonephritis patients with a lower risk of cardiovascular death.
As in previous studies, we found in transplant recipients a small, but significantly increased risk of malignancy-related mortality after adjustment for age and sex [5, 32] . The highest increased risk was observed among younger patients and was similar to the 10-fold increased risk of cancer among patients who start RRT in childhood age that we found in a previous study [32] . Rates in the elderly were only slightly, if at all, increased, which has been shown before [33] . Interestingly, the MRR was higher on dialysis than on transplantation which could be explained by the potentially increased risk of graftloss among cancer patients due to the use of chemotherapy [34, 35] and the reduction of immunosuppressive medication, leading to a subsequent death on dialysis. We tried to avoid this effect by attributing those deaths on dialysis within 60 days after graft-loss due to transplantation [36] , but still this might not be sufficient for malignancies. The death rate due to cancer, was slightly lower than that of the number of new cancer cases [4, 5] and also as compared with studies from Australia and New Zealand [37] . This might be explained by the high prevalence of basal cell skin cancer and squamous cell carcinoma in patients on dialysis and in transplant recipients, which are often not fatal [4, 34] . A potentially more dangerous combination of the use of immunosuppressants and the higher sun exposure in Australia and New Zealand could have led to increased risks of fatal malignancies in that area [26, 32] .
Limitations
A few limitations of our study need to be noted for adequate interpretation of our results. First, the cause of death was unknown in approximately 15% of all patients on RRT while it was missing in only 0.16% of the general population. This may have resulted in underestimation of our MRRs. Within the ERA-EDTA Registry only one cause of death can be reported. Therefore there may have been overlap between patients who had both a malignancy and an infection at death. This may have led to an underestimation of both the IRR of cancer and of infections. This different percentage in the category 'unknown' may be explained by the slightly different method of collecting cause of death data between the patients and the general population. Causes of death among the RRT population were collected by the treating nephrologist and autopsies will have been performed in only very few cases. Causes of death within the general population are commonly recorded by the physician who confirmed the death and thereafter sent it to the statistics office, resulting in relatively few missing causes of death. However, it seems unlikely that death due to infection or malignancy was missed by a nephrologist. Second, malignancies contributing to a decision to abandon RRT may have remained unreported. This means that the category 'dialysis withdrawal' might also include some patients with malignancies, leading to a slight underestimation of the percentage of patients dying from malignancies. Finally, we combined person-time on dialysis for the F I G U R E 2 : Differences in sex and age groups for the prevalence of multisystem disease in dialysis patients (A) and transplant recipients (B).
first and subsequent dialysis periods. Recent studies suggest that transplant failure patients returning on dialysis have a higher (infection-related) mortality compared with naïve transplant patients [38, 39] . Because we investigated prevalent mortality rates, for dialysis patients we included all time on dialysis. Performing a sensitivity analysis including only the first dialysis period did not alter our conclusions.
CO N C L U S I O N
The present study shows that infection-related mortality is highly increased among both dialysis patients and kidney transplant recipients. Young patients on dialysis, especially females with multisystem disease, are at a relatively high risk of infection-related mortality. They deserve special attention because of their excess risk of infection-related death. Physicians must be aware of factors increasing the risk of infection-related death and try to avoid them. Research into the mechanisms, prevention and better treatment of infections deserves a prominent place on the research agenda.
